Responding to FDA Form 483: USFDA Issues
The USFDA has released a draft guidance titled “Responding to FDA Form 483 Observations at
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
